Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs Prudential Financial Inc (PRU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs Prudential Financial Inc — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.42 (market cap $12.58B), while Prudential Financial Inc trades at $113.09 (market cap $39.17B). The key difference: Prudential Financial Inc is far larger — about 3.1× Halozyme Therapeutics Inc. Common Stock's market cap, and Prudential Financial Inc pays a 4.93% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and Prudential Financial Inc for 145 Days on average.
| HALO | PRU | |
|---|---|---|
Market Cap | $12.58B | $39.17B |
Volume | 2,179,278 | 1,436,917 |
Sector | Health | Financials |
52-Week High | $115.22 | $125.13 |
52-Week Low | $61.63 | $92.00 |
Typical Hold Time | 1 Days | 145 Days |
Enterprise Value | $14.49B | $67.95B |
Dividend Yield | — | 4.93% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Prudential Financial (PRU) trades at $113.53, up 1.04% with a bearish technical signal despite recent earnings beats. The stock shows attractive valuation metrics with P/E of 10.29 and P/S of 0.61, while maintaining solid profitability with 6.04% net margin and 12.46% ROE. Recent developments include strategic partnerships, the Alexforbes stake sale, and rebranding to Prudential Wealth Advisors, reflecting ongoing business transformation.
PRU presents a mixed outlook with strong fundamentals offset by technical weakness. The company's $3 billion capital rotation plan and focus on core businesses provide growth potential, but investor sentiment remains cautious with 67.57% hold ratings. Key risks include execution of strategic initiatives and interest rate sensitivity, while current valuation below consensus target offers potential upside for patient investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About Prudential Financial Inc
Prudential Financial is a large, diversified insurance company offering annuities, life insurance, retirement plan services, and asset management products. While it operates in a number of countries, the vast majority of revenue is generated in the United States and Japan. The company's investment management business, PGIM, contributes approximately 15% of its earnings and has over $1.5 trillion in assets under management. The U.S. businesses are responsible for about 45% of earnings and can be classified into Institutional Retirement Strategies, Individual Retirement Strategies, Group Insurance, Individual Life Insurance, and Assurance IQ. Finally, the international business segment of the company contributes approximately 40% of earnings with a strong market position in Japan.
Read more on PRU →
